Corcept Therapeutics Incorporated (CORT)

Nasdaq · Healthcare · Biotechnology
$63.62-2.09%As of 2026-11-22 · USD
Last session low $62.81Last session high $65.13
52-week low $28.6652-week high $126.38
Market cap
$6.96B
Sector
Healthcare
P/E (TTM)
47.8x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)21.4In the oversold range (below 30)
MACD (12, 26, 9)-9.75Below its signal line (-9.68); histogram -0.07
Bollinger %B (20, 2)7%Inside the bands (61.75 to 90.25)
SMA 2076.00Price is 16.3% below
SMA 5099.04Price is 35.8% below
SMA 20077.18Price is 17.6% below
ATR (20)7.84% of priceAverage true range per day
52-week position36%In the middle of the 28.66 to 126.38 range

About Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Insider filings, 90 daysNo purchases and 17 sales (about $27.8M).
Latest fiscal yearEnded 2025-12-31: revenue of $761.41M and an operating margin of 5.9%.

More in Biotechnology